Lars Klareskog

Has grant

Prof

Karolinska Institutet

Sweden

Research Interests

Explore related searches

Professors in Sweden Professors in Immunology Immunology professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Prof. Lars Klareskog is a faculty member at Karolinska Institutet in Sweden. His research primarily focuses on rheumatoid arthritis, including the impact of genetic variants on treatment outcomes, the relationship between comorbidities and disease progression, and the role of autoantibodies in early stages of the condition. He has published extensively on the risk factors associated with rheumatoid arthritis and strategies for prevention and treatment.

Recent Grants

Grant: Close

Crafoord Prize

Open Date: 2013-05-01

Close Date: 2013-05-01

Grant: Close

PRIMI

Open Date: 2010-10-01

Close Date: 2015-10-01

Grant: Close

Söderberg Prize

Open Date: 2010-04-01

Close Date: 2010-04-01

Grant: Close

Research to prevent disability caused by rheumatic diseases

Open Date: 2006-06-01

Close Date: 2011-06-01

Grant: Close

AutoCure

Open Date: 2006-04-01

Close Date: 2011-03-01

Articles (14)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Lars Klareskog

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (14)

In early rheumatoid arthritis, comorbidities do not explain the increased risk of failure to reach remission in patients with obesity

Common genetic variants do not impact clinical prediction of methotrexate treatment outcomes in early rheumatoid arthritis

The peculiar features, diversity and impact of citrulline-reactive autoantibodies

In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammation

Rheumatology tolerance for cure (RTCure) – an IMI project aimed at prevention and cure of RA

Identification of circulating autoantibodies to non-modified proteins associated with ACPA status in early rheumatoid arthritis

Divergent and dominant anti-inflammatory effects of patient-derived anticitrullinated protein antibodies (ACPA) in arthritis development

Occupational inhalable agents constitute major risk factors for rheumatoid arthritis, particularly in the context of genetic predisposition and smoking

Prevention vs treatment of rheumatoid arthritis

Allergic conditions and risk of rheumatoid arthritis: a Swedish case–control study

Passive smoking in childhood accelerates RA risk for smokers

Sleep problems in rheumatoid arthritis over 12 years from diagnosis: results from the Swedish EIRA study

How to communicate in science

The importance of differences; On environment and its interactions with genes and immunity in the causation of rheumatoid arthritis

Collaborators (5)

Per-Johan Jakobson

Marie Holmqvist

Johan Askling

Vivianne Malmström

Leonid Padyukov

Make your next move.